Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4
Clinical Trial Report
Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 25,741 | Dovepress* | 22,532+ | 1,428 | 23,960 | |
| PubMed Central* | 3,209 | 306 | 3,515 | ||
| Totals | 25,741 | 1,734 | 27,475 | ||
| *Since 12 April 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 309 | 0 | 0 | 0 | 4 | 305 |
View citations on PubMed Central and Google Scholar